Chimicles & Tikellis LLP announces that it is investigating potential claims on behalf of investors who purchased securities of Inventure Foods, Inc. (“Inventure” or the “Company”) (Nasdaq: SNAK) prior to April 24, 2015, for potential violations of federal securities laws.
Inventure is a marketer and manufacturer of purportedly healthy, natural and indulgent specialty snack food brands. In September 2014 the Company held a secondary offering. In the offering’s Registration Statement, public statements and other documents filed with the SEC in the months after the offering, Inventure has repeatedly stressed the quality of its products enhanced by its innovative manufacturing processes.
On January 18 and April 23, 2015, the Company announced two distinct voluntary recalls of products due to the finding of Listeria monocytogenes in its Jefferson, Georgia facility. The stock market reacted to the negative news. On April 24, 2015, Inventure’s common stock closed at $8.71, representing a more than 30% price decline since the September 2014 offering.
Among other things, our attorneys are investigating whether Inventure, prior to April 24, 2015, had adequately disclosed to investors the efficacy of its internal controls over its food manufacturing processes. If you possess information relevant to this investigation, or purchased stock in SNAK prior to April 24, 2015 and would like to discuss your legal rights and options, please contact attorney Christina Saler, Esq. by telephone at (610) 642-8500 or by email at email@example.com.
NOTE: To date, no cases have been filed against Inventure, and therefore no one is seeking to represent the rights of investors in a proposed class action. If you are interested in learning more about our investigation and your legal rights, please contact us immediately.
If you purchased stock in Inventure prior to April 24, 2015, please use the “Email us about this Case” button below to contact the attorneys or call us at (610) 642-8500.